New York, NY -- (SBWIRE) -- 12/07/2013 -- StockMarketIntel.com issues a special report on the following stocks: Coronado Biosciences Inc (NASDAQ:CNDO), Kandi Technologies Group Inc (NASDAQ:KNDI), Elephant Talk Communications Corp (NYSEMKT:ETAK), Arca Biopharma Inc (NASDAQ:ABIO).
Coronado Biosciences Inc (NASDAQ:CNDO) ended its recent business day with the advanced of 3.61% and closed at the price of $1.72 after opening at $1.67. The stock traded during its last trading session with the total volume of 2.21 million shares, as compared to its average volume of 1.18 million shares. Coronado Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
Will CNDO Continue To Move Higher? Find Out Here
Kandi Technologies Group Inc (NASDAQ:KNDI) remained among the day bullish 4.82% and traded with volume of 2.19 million shares in the last session, as compared to average volume of 913.700 shares. In comparison with 52 week range of $3.37 - $9.20, it faced lowest price of $6.90 during the last trading session whereas its day highest price was $7.35. The company’s total market capitalization is $265.14 million, along with 36.89 million shares outstanding. Kandi Technologies Group, Inc., through its subsidiaries, engages in the design, development, manufacture, and commercialization of various vehicles.
Will KNDI Continue To Move Higher? Find Out Here
Elephant Talk Communications Corp (NYSEMKT:ETAK) showed 2.18 million shares in volume during the last trading session, while the average trading volume remained 658.111 shares. The stock kicked off its trading session at $1.06 and closed at $1.18 after rallied 11.32%. Elephant talk Communications Corporation operates as mobile software defined network architecture vendor in Europe, the Middle East, Africa, and the Americas.
Will ETAK Continue To Move Higher? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) stock traded during its last trading session with the total traded volume of 2.11 million shares versus its average volume of 1.51 million shares. The company opened its trade at the price of $1.61 and its closing price was $1.55 after fell -6.06% for the day. ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases.
Will ABIO Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)